BioStem Technologies, Inc. announced that company management will present at the 46th Annual TD Cowen Healthcare Conference in Boston, Massachusetts. The presentation is scheduled for Monday, March 2, 2026, at 3:50 pm ET. Interested parties can access live and archived webcasts of the presentations through the investors section of the company's website at https://ir.biostemtechnologies.com.
The company focuses on developing, manufacturing, and commercializing perinatal tissue-derived products for advanced wound care and regenerative therapies. BioStem Technologies leverages its proprietary BioRetain® processing method, which maintains growth factors and preserves tissue structure based on the latest research in regenerative medicine. This technology represents a significant advancement in tissue processing that could impact treatment outcomes for patients requiring wound care and regenerative solutions.
BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks. These systems comply with current Good Tissue Practices and current Good Manufacturing Processes, ensuring product safety and consistency. The company's portfolio includes several brands: VENDAJE®, VENDAJE AC®, American Amnion™, American Amnion AC™, and Neox® and Clarix® product lines.
For business and technology leaders, BioStem's presentation at this prominent healthcare conference signals the company's continued focus on innovation in the MedTech sector. The regenerative medicine market represents a growing segment within healthcare technology, with increasing demand for advanced wound care solutions. BioStem's approach to perinatal tissue processing could have implications for healthcare providers seeking effective regenerative therapies and for investors monitoring developments in medical technology.
The company maintains an online presence where additional information is available at https://biostemtechnologies.com. The latest news and updates relating to the company are accessible through its newsroom at https://tinyurl.com/bsemnewsroom. BioStem's participation in industry conferences like the TD Cowen Healthcare Conference provides visibility for its technologies and may influence investment decisions and partnership opportunities within the healthcare technology sector.
